• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Mylan

Mylan

Lord Abbett Small Cap Value R3 LRSRX 3 Star

Last Price$24.75Day Change (%)0.04%
Open Price$24.75Day Change ($)0.01
Day Range24.75–24.7552-Week Range17.58–25.66

As of Sat 12/09/2016 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mylan NV Investors

    The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mylan NV Investors

  2. Rate Hikes? Not in 2015

    Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...

  3. What Migration Can (and Can’t) Do for a Country’s GDP

    Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...

  4. Fitch:US Healthcare Outlook Stable Despite Political Uncertainty

    Fitch:US Healthcare Outlook Stable Despite Political Uncertainty

  5. Amyotrophic Lateral Sclerosis Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are GNT Pharma, Amkor Pharma & Sanofi - Research and Markets

    Amyotrophic Lateral Sclerosis Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are GNT Pharma, Amkor Pharma & Sanofi - Research and Markets

  6. Stockton is Bankrupt: Now What?

    Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.

  7. Five Funds That Have Surfed 2009's Wild Waves Well

    These mutual funds have far more than their recent success going for them.

  8. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

  9. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?

    Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.

  10. Our Outlook for the Credit Markets

    Rising interest rates have taken their toll, but as the Fed delays dialing back on stimulus, investors are poised to recapture some of their losses.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.